Jupiter Neurosciences, Number Of Employees vs. EBITDA
| JUNS Stock | USD 9.73 1.13 10.41% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Return On Equity | 0.54 | 0.8246 |
|
|
For Jupiter Neurosciences, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Jupiter Neurosciences, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Jupiter Neurosciences, Common utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Jupiter Neurosciences,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Jupiter Neurosciences, Common over time as well as its relative position and ranking within its peers.
Jupiter |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Jupiter Neurosciences,. If investors know Jupiter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Jupiter Neurosciences, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Jupiter Neurosciences, is measured differently than its book value, which is the value of Jupiter that is recorded on the company's balance sheet. Investors also form their own opinion of Jupiter Neurosciences,'s value that differs from its market value or its book value, called intrinsic value, which is Jupiter Neurosciences,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Jupiter Neurosciences,'s market value can be influenced by many factors that don't directly affect Jupiter Neurosciences,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Jupiter Neurosciences,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Jupiter Neurosciences, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Jupiter Neurosciences,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Jupiter Neurosciences, EBITDA vs. Number Of Employees Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Jupiter Neurosciences,'s current stock value. Our valuation model uses many indicators to compare Jupiter Neurosciences, value to that of its competitors to determine the firm's financial worth. Jupiter Neurosciences, Common is rated fourth overall in number of employees category among its peers. It is rated third overall in ebitda category among its peers . At this time, Jupiter Neurosciences,'s EBITDA is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Jupiter Neurosciences, by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Jupiter Number Of Employees vs. Competition
Jupiter Neurosciences, Common is rated fourth overall in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 30.0. Jupiter Neurosciences, retains roughly 4.0 in number of employees claiming about 13% of stocks in Biotechnology industry.
Jupiter EBITDA vs. Number Of Employees
Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Jupiter Neurosciences, |
| = | 4 |
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Jupiter Neurosciences, |
| = | (4.56 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Jupiter EBITDA Comparison
Jupiter Neurosciences, is currently under evaluation in ebitda category among its peers.
Jupiter Neurosciences, Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Jupiter Neurosciences,, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Jupiter Neurosciences, will eventually generate negative long term returns. The profitability progress is the general direction of Jupiter Neurosciences,'s change in net profit over the period of time. It can combine multiple indicators of Jupiter Neurosciences,, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -3.9 M | -4.1 M | |
| Income Before Tax | -4.8 M | -5 M | |
| Total Other Income Expense Net | -912.9 K | -958.6 K | |
| Net Loss | -4.8 M | -5 M | |
| Income Tax Expense | 161.3 K | 143.3 K | |
| Net Loss | (0.15) | (0.15) | |
| Income Quality | 0.10 | 0.15 | |
| Net Income Per E B T | 0.94 | 0.83 |
Jupiter Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Jupiter Neurosciences,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Jupiter Neurosciences, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Jupiter Neurosciences,'s important profitability drivers and their relationship over time.
Use Jupiter Neurosciences, in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Jupiter Neurosciences, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jupiter Neurosciences, will appreciate offsetting losses from the drop in the long position's value.Jupiter Neurosciences, Pair Trading
Jupiter Neurosciences, Common Pair Trading Analysis
The ability to find closely correlated positions to Jupiter Neurosciences, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Jupiter Neurosciences, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Jupiter Neurosciences, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Jupiter Neurosciences, Common to buy it.
The correlation of Jupiter Neurosciences, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Jupiter Neurosciences, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Jupiter Neurosciences, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Jupiter Neurosciences, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Jupiter Neurosciences, position
In addition to having Jupiter Neurosciences, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run EUR Crypto Assets Thematic Idea Now
EUR Crypto Assets
An experimental p2p digital currency that is accepted by many vendors in Euro. The EUR Crypto Assets theme has 0 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize EUR Crypto Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Jupiter Stock Analysis
When running Jupiter Neurosciences,'s price analysis, check to measure Jupiter Neurosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jupiter Neurosciences, is operating at the current time. Most of Jupiter Neurosciences,'s value examination focuses on studying past and present price action to predict the probability of Jupiter Neurosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jupiter Neurosciences,'s price. Additionally, you may evaluate how the addition of Jupiter Neurosciences, to your portfolios can decrease your overall portfolio volatility.